â– PHYSIOLOGICAL CORE: Autoimmune Hemolytic Anemia (AIHA) involves antibody-mediated destruction of red blood cells, classified by the thermal characteristics of the autoantibodies.
â– IMMUNOLOGICAL REWIRINGS:
1. Warm AIHA (IgG-Mediated):
- Antibody: IgG autoantibodies point at RBC membrane proteins (e.g., Rh antigens), binding optimally at core body temperature (37°C).
- Clearance: Splenic macrophages recognize the Fc portion of IgG, partial-phagocytosing the RBC to form spherocytes, which are cleared extravascularly.
2. Cold AIHA (IgM-Mediated):
- Antibody: IgM autoantibodies bind to RBC membrane antigens (e.g., I antigen) at cold temperatures (<30°C, as in cold extremities).
- Clearance: IgM binds and activates the classical complement pathway. Upon warming, IgM dissociates, but C3b remains bound to the RBC, promoting hepatic phagocytosis or direct intravascular lysis.
â– ETIOLOGICAL PROFILE & RISK FACTORS:
Major etiological drivers include genetic predispositions (autosomal patterns and chromosomal translocations) and environmental triggers like toxic chemical exposure, mechanical stress, or chronic viral infections.
â– CLINICAL CASE SUMMARY:
A 45-year-old patient presented with acute clinical deterioration. Aggressive initial stabilization, molecular monitoring, and specialized pathology screening confirmed the classic disease hallmarks.
[HY-BOARD-1023]
🌟 Dynamic Clinical Key:
Direct Coombs Testing (DAT) of red blood cells confirms AIHA. Warm AIHA is associated with SLE, chronic lymphocytic leukemia, or drugs (penicillin). Cold AIHA is associated with Mycoplasma pneumoniae infections or infectious mononucleosis. Assess family history and genetic screens to identify high-risk patients before symptoms present. Clinical vigilance during early presentation prevents progression along the severe outcome pathway.